Vertex Pharmaceuticals (VRTX) Change in Intangibles (2014 - 2024)

Vertex Pharmaceuticals (VRTX) recorded quarterly Change in Intangibles of $375.4 million in Q4 2024, up 4975.32% quarter-over-quarter from -$7.7 million in Q2 2024, and up 547.24% on a YoY basis from $58.0 million in Q1 2024.

Vertex Pharmaceuticals (VRTX) Change in Intangibles (2014 - 2024) Analysis & Trends

Vertex Pharmaceuticals' Change in Intangibles history runs 3 years deep, the most recent figure standing at $375.4 million for Q4 2024.

  • In Q4 2024, Change in Intangibles rose 547.24% year-over-year to $375.4 million; the TTM figure through Sep 2025 stood at $375.4 million (up 389.44% YoY), while the FY2024 annual figure was $187.7 million, up 223.62% from the prior year.
  • Change in Intangibles was $375.4 million for Q4 2024 at Vertex Pharmaceuticals, up from -$7.7 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $375.4 million in Q4 2024 to a low of -$180.0 million in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 375.40 Mn
Dec 31, 2024 375.40 Mn
Jun 30, 2024 -7.70 Mn
Jun 30, 2024 -7.70 Mn
Mar 31, 2024 -180.00 Mn
Mar 31, 2024 -180.00 Mn
Dec 31, 2023 58.00 Mn
Dec 31, 2023 58.00 Mn
Dec 31, 2014 10.00 Mn
Dec 31, 2014 10.00 Mn